Pulmolite Market Report 2026

Pulmolite Market Overview

• The Pulmolite market growth in the historic period has been driven by expansion of nuclear medicine infrastructure, increased prevalence of pulmonary embolism diagnosis • Market expansion is supported by advancements in nuclear imaging technologies, rising demand for precise pulmonary diagnostics • Growth Driver: Rising Respiratory Disorders Driving Growth In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pulmolite Market?

Pulmolite is a radiopharmaceutical agent used in medical imaging, specifically lung perfusion scans, to assess blood flow in the lungs. It consists of technetium-99m-labeled particles that are injected into the bloodstream and accumulate in the lungs. Pulmolite helps in diagnosing conditions such as pulmonary embolism and evaluating lung function before surgery. The main indications of pulmolite are respiratory conditions, allergies, cough relief, and cold symptoms. Respiratory conditions refer to diseases affecting the lungs and airways, and pulmolite is used to improve oxygenation and support lung function in these patients. It is distributed through channels such as direct sales, retail pharmacies, e-commerce platforms, and wholesalers and utilized by end users such as hospitals, clinics, ambulatory care, and homecare.

What Is The Pulmolite Market Growth Forecast?

The growth in the forecast period can be attributed to advancements in nuclear imaging technologies, rising demand for precise pulmonary diagnostics, expansion of outpatient diagnostic centers, increasing investment in nuclear medicine facilities, growing emphasis on early and accurate respiratory diagnosis. Major trends in the forecast period include increasing use of radiopharmaceuticals in diagnostic imaging, rising demand for lung perfusion scans, expansion of nuclear medicine procedures, growing focus on early detection of pulmonary disorders, improved radiotracer formulation stability.

Global Pulmolite Market Segmentation

1) By Indication: Respiratory Conditions, Allergies, Cough Relief, Cold Symptoms 2) By Distribution Channel: Direct Sales, Retail Pharmacies, E-Commerce Platforms, Wholesalers 3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

What Are The Drivers Of The Pulmolite Market?

The growing prevalence of respiratory disorders is expected to drive the pulmolite market. Respiratory disorders are defined as pathological conditions that impact the respiratory system, which includes the upper and lower airways, lungs, and associated structures. Respiratory disorders can arise from a variety of factors such as smoking and tobacco use, infections, environmental pollutants, allergens, occupational hazards, and genetic factors. Pulmolite is used in the treatment of respiratory disorders by improving oxygenation and supporting lung function. It works by enhancing the delivery of oxygen to the lungs and optimizing their ability to exchange gases effectively. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, approximately 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people, or 11% of the population, living with asthma, and 638,000 people, or 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Therefore, the rising incidence of these disorders is fueling the growth of the pulmolite industry. The rising healthcare expenditure is expected to propel the growth of the pulmolite market going forward. Healthcare expenditure refers to the total amount spent on healthcare goods and services, including personal health care, preventive services, and public health activities, aimed at improving health outcomes within a specific period. Healthcare expenditure is rising due to an aging population, chronic diseases, advanced medical technology, high drug prices, inefficient payment models, and increased demand for services. Healthcare expenditure boosts demand for Pulmolite by advancing organ preservation technologies and improving access to lung transplantation procedures. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the rising healthcare expenditure is driving the pulmolite industry. The rising air pollution level is expected to propel the growth of the pulmolite market going forward. Air pollution refers to the presence of harmful substances, such as chemicals, particles, and gases, in the air that can negatively impact health, ecosystems, and the climate. The rise in air pollution is driven by factors such as increased industrial activity, vehicle emissions, deforestation, and fossil fuel consumption. Pulmolite aids in assessing lung damage caused by air pollution through diagnostic imaging of pulmonary function and blood flow. For instance, in August 2024, according to the US Environmental Protection Agency, a US-based governmental agency, in 2023, approximately 66 million tons of pollutants were released into the atmosphere in the United States. Therefore, the rising air pollution level is driving the pulmolite industry.

Key Players In The Global Pulmolite Market

Major companies operating in the pulmolite market are Solariz Healthcare Pvt Ltd

Regional Insights

North America was the largest region in the pulmolite market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Pulmolite Market?

The pulmolite market consists of sales of acebrophyline and acetylcysteine tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pulmolite Market Report 2026?

The pulmolite market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pulmolite industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.